Rt. Burks et al., MICROPAPILLARY SEROUS CARCINOMA OF THE OVARY - A DISTINCTIVE LOW-GRADE CARCINOMA RELATED TO SEROUS BORDERLINE TUMORS, The American journal of surgical pathology, 20(11), 1996, pp. 1319-1330
According to the International Federation of Gynecology and Obstetrics
(FIGO) and the World Health Organization (WHO), stromal invasion, def
ined as destructive infiltrative growth, is the sole criterion used to
distinguish serous borderline tumors from invasive serous carcinomas
of the ovary. Although this criterion effectively identifies most mali
gnant tumors, it does not permit the identification of a small subset
of well-differentiated ovarian carcinomas that do not display destruct
ive infiltrative growth but that may be associated with malignant beha
vior. In this study, we describe a group of such serous neoplasms that
have distinctive morphologic features and that are often associated w
ith progressive, invasive disease. We have designated these tumors mic
ropapillary, serous carcinomas (MPSC). They are characterized by a fil
igree pattern of highly complex micropapillae arising directly from la
rge, bulbous papillary structures. The micropapillae are covered by ro
und to cuboidal cells with a high nuclear-to-cytoplasmic ratio. Typica
l serous borderline tumors tend to display a hierarchical pattern of b
ranching terminating in small papillae or tufts, and the cells coverin
g the papillae tend to be more columnar and often ciliated compared wi
th cells of MPSC. We reviewed more than 400 cases of serous ovarian bo
rderline tumors and well-differentiated serous carcinomas and identifi
ed 26 cases of MPSC. Seventeen tumors lacked destructive infiltrative
growth (noninvasive), and nine contained areas of invasion ranging fro
m minimal to extensive. Fight of the 26 tumors were stage I, and none
of the patients developed recurrence whether or not their tumors had d
emonstrable invasion. In contrast, of the 16 women presenting with sta
ge II disease or higher and who had more than 1 year of follow-up, eig
ht (50%) have either died of intra-abdominal carcinomatosis or are ali
ve with carcinoma. Twenty-four (92%) of MPSCs contained areas of serou
s borderline tumor. The frequent association of MPSCs with serous bord
erline tumors suggests that MPSCs arise from the latter and may accoun
t for the few cases of serous borderline tumors that have been associa
ted with progression to invasive carcinoma.